Champions Oncology is a leading brand dedicated to transforming drug discovery in the pharmaceutical industry. With a strong commitment to innovative treatments, they provide comprehensive research and development solutions throughout the entire drug development lifecycle. Their services encompass a range of offerings, including screens using both commercially-available and custom cell lines, as well as studies leveraging syngeneic or traditional patient-derived studies xenograft (PDX) models.

They also excel in modeling treatment response in the clinic. Founded in 2007, Champions Oncology pioneered the use of groundbreaking Patient-derived Xenograft Models (PDX Models) to test targeted therapies. Through strategically localized clinical sites and laboratories worldwide, they efficiently obtain samples and coordinate studies, ensuring faster generation of therapeutic testing results.

At Champions Oncology, they pride themselves on being part of your scientific team, providing high-quality data on time, every time. With their expertise and dedication, they are committed to meeting today's needs and innovating for tomorrow's challenges in the pursuit of effective cancer treatments